We recently demonstrated that Angiotensin-(3−4) ], an Ang II-derived dipeptide, overcomes inhibition of plasma membrane Ca 2 + -ATPase promoted by nanomolar concentrations of Ang II in basolateral membranes of renal proximal tubule cells, with involvement of a so far unknown AT 2 R-dependent and NOindependent mechanism. The present study investigates the signaling pathway triggered by Ang-(3−4) that is responsible for counteracting the inhibitory effect of Ang II, and attempts to elucidate the functional interaction of the dipeptide with Ang II at the level of AT 2 R. Stimulation by cholera toxin of G s α protein structurally linked to AT 2 R − as revealed by their co-immunoprecipitation − mimicked the effect of Ang-(3−4) on Ca 2 + -ATPase activity. Furthermore, addition of dibutyril-cAMP (db-cAMP) mimicked Ang-(3−4), whereas the specific PKA inhibitor, PKAi (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) peptide, suppressed the counter-regulatory effect of Ang-(3−4) and the AT 2 R agonist, CGP42112A. Membrane-associated PKA activity was stimulated by Ang-(3−4) or CGP42112A to comparable levels as db-cAMP, and the Ang-(3-4) effect was abrogated by the AT 2 R antagonist PD123319, whereas the AT 1 R antagonist Losartan had no effect. Ang-(3−4) stimulated PKA-mediated phosphorylation of Ca -ATPase through an AT 2 R/cAMP/PKA pathway, after inducing conformational changes in AT 2 R that results in generation of higher-affinity sites for Ang II.
Introduction
Recently, new components of the renin angiotensin system (RAS) have been described including bioactive shorter peptides derived from Angiotensin II (Ang II), such as Ang III, Ang IV and Ang-(1−7) (for review, see [1] ). These metabolites exert their effects by interacting with the classic receptors described for Ang II, the AT 1 and AT 2 receptors (AT 1 R and AT 2 R), or acting through their own receptors, e.g. AT 4 R and AT (1−7) R (MAS), which are specific for Ang IV and Ang-(1−7), respectively [2, 3] . Actions that are similar or opposite to those generated upon binding of Ang II to its receptors can be observed, depending on the type of receptor being activated.
Recently, we found parallel pathways in the renal cortex that can generate a very short, potent Ang II-derived metabolite, Ang-(3−4) [4] . Importantly, this Ang II-derived peptide displays antihypertensive actions in vivo and in vitro [5, 6] . Furthermore, we demonstrated [7] that Ang-(3−4) counteracts -with femtomolar affinity -the inhibition that 10 −10 mol/L Ang II promotes − via PKC − on Ca 
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j o u r n a l h o m e p a g e : w w w . e l s e v i e r . c o m / l o c a t e / r e g p e p the basolateral membranes of kidney proximal tubule cells [8] . As this ATPase is responsible for the fine tuning of cytosolic Ca
2+
, and proximal reabsorption of fluid is modulated by the intracellular activity of this cation [9] , the influence of Ang-(3−4) on transepithelial Ca 2 + fluxes emerges as a novel physiological process for controlling the volume of body fluid compartments, and consequently, of arterial pressure. To date, the signaling cascade triggered by this potent dipeptide remains unknown.
We have demonstrated that cAMP-dependent protein kinase (PKA) activates the plasma membrane Ca 2 + -ATPase in proximal tubules [10] . PKA activation antagonized the influence of PKC on renal (Na + +K + )ATPase [11] and the recently cloned and purified [12] ouabain-insensitive Na + -ATPase [13] through interacting with pathways that involve Ang II receptors. Therefore, we hypothesized that Ang-(3−4)-induced reactivation of the Ang II-inhibited renal Ca -ATPase that is inhibited by physiological Ang II concentrations.
Experimental procedures

Animal care
Santa Inês sheep were raised on ranches in Jequié (BA, Brazil) and Montes Claros (MG, Brazil) that are under supervision of the Brazilian Ministry of Agriculture. The health of the animals was certified by a licensed veterinarian from an authorized slaughterhouse. Sheep were used due to the fact that their kidneys produce abundant levels of Ca 2 + -ATPase and because their kidneys are frequently discarded as wastage. This avoids use of experimental animals such as rats, which would be sacrificed for their kidneys only. This study was approved by the local ethics committee for the use of animals in biomedical assays (IBCCF No.104), which follows the recommendations of the National Institute of Health (NIH) guide for the care and use of laboratory animals.
Materials
Human embryonic kidney cells (HEK 293T) were purchased from American Type Culture Collection. 3 H-Ang II was obtained from GE Healthcare. Unlabeled Ang II, the AT 2 R agonist CGP42112A, cholera toxin (CTX), dibutyril cyclic AMP (db-cAMP), histone H8 and the AT 2 R antagonist PD123319 were bought from Sigma-Aldrich; the PKA inhibitor peptide (PKAi) was purchased from Calbiochem. Ang-(3−4) was synthesized by EZBiolab. Losartan was from Merck, Sharp & Dohme, and Protein A/G PLUS-agarose from Santa Cruz Biotechnology. The 5f10 antibody and phospho-(Ser/Thr) PKA substrate antibodies were purchased from Thermo Scientific and Cell Signaling Inc., respectively. The anti-AT 2 R (anti-goat and anti-rabbit) and anti-G s α protein antibodies were obtained from Santa Cruz Biotechnology and Calbiochem, respectively. Maia and coworkers [14] . The radioactivity recovered in assays was quantified using a liquid scintillation counter.
Cell culture and transfections
HEK 293T cells were maintained in Dulbecco's modified Eagle's medium (DMEM) (Invitrogen) supplemented with 10% fetal bovine serum, gentamycin sulfate (50 μg/ml) and glutamine (2 mmol/L) in a 5% CO 2 /air atmosphere. Transient transfections of the cells were performed using the calcium phosphate precipitation method described by Gether and 
Preparation of basolateral membranes from kidney proximal tubule cells
Membranes were isolated from the outer cortex (cortex corticis) of sheep kidneys [7] . More than 90% of the cell population in this region comprises proximal tubules [16] . The basolateral membrane-enriched fraction was isolated and purified using the Percoll gradient method [10, 17] . Controls for enrichment with basolateral membranes and for minimal residual contamination with other intracellular membranes have been described elsewhere [17] . 
Plasma membrane Ca
Determination of cAMP-dependent protein kinase activity
The PKA activity was measured through the incorporation of the γ-phosphoryl group of [γ- 32 P]ATP into histone in the absence or presence of PKAi, a specific PKA inhibitor [10, 18] . The basolateral membranes (0.7 mg/ml in 0.1 ml final volume) were added to medium containing 20 mmol/L HEPES-TRIS (pH 7.0), 4 mmol/L MgCl 2 , 10 nmol/L 3-isobutyl-1-methylxanthine (IBMX) and 1.5 mg/ml histone H8, with or without 100 nmol/L PKAi. Other additions are indicated in the corresponding figure legends. After mixing, histone phosphorylation was initiated through the addition of 10 μmol/L [γ- 32 P]ATP (10 Ci/mmol), carried out at 37°C for 10 min and arrested by adding 0.1 ml trichloroacetic acid (TCA) (40%, w/v). After vigorous stirring, samples were filtered under vacuum (Millipore filters, 0.45 μm pore diameter). The filters were washed with 8 ml 20% TCA and 9 ml 0.1 mol/L phosphate buffer (pH 7.0) to remove unused [γ- 32 P] ATP, and counted using a liquid scintillation counter.
Immunoprecipitation, SDS-PAGE and immunodetection of the AT 2 R/G s α complex
Membranes (1 mg/ml) were solubilized in a sucrose solution containing 0.1% (w/v) 3-[(3-cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS) for 30 min at room temperature. Ten microliters of primary anti-goat polyclonal antibody of AT 2 R was mixed with 1 ml membrane suspension and incubated at 4°C for 1 h, supplemented with 20 μL of protein A/G PLUS-agarose and incubated overnight with gentle stirring. The samples were centrifuged at 1000 g for 5 min and the supernatant retained as a control for the immunoprecipitation procedure. The pellet was washed three times with Tris-buffered saline (TBS) before being heated in a water-bath to 100°C for 4 min with 40 μL SDS-PAGE sample buffer. After final centrifugation at 16,100 g for 2 min, the supernatant was subjected to SDS-PAGE followed by Western blotting.
Sample proteins were separated using SDS-PAGE (10%) and transferred to nitrocellulose membranes at 350 mA. The membranes were incubated with 5% non-fat milk in TBS (pH 7.6) for 1 h to prevent non-specific binding and probed with rabbit polyclonal anti-G s α antibody (1:1000 dilution) for 1 h at room temperature under gentle stirring, washed three times with TBS containing 0.1% Tween 20 (TBST), exposed to the secondary antibody, washed again and visualized using ECL™. For a control of the efficiency of immunoprecipitation, AT 2 R was immunodetected using an anti-rabbit polyclonal antibody (1:500) after stripping of the nitrocellulose membrane. AT 2 R and G s α have a molecular mass close to that of the heavy chain of IgG. Therefore, the strategy was to immunoprecipitate the receptors using an anti-goat polyclonal antibody, followed by a rabbit G s α or AT 2 R polyclonal antibody for the Western blotting, to minimize the appearance of unspecific bands. A negative control (Western blotting without membrane proteins) was used for precise localization of the IgG bands. -ATPase antibody (5f10 anti-mouse antibody; 1:500 dilution) and incubated for 1 h at 4°C before 20 μL A/G PLUS-agarose was added. The mixtures were maintained under gentle agitation at 4°C overnight, and centrifuged at 1000 g for 5 min at the same temperature. The sediments were washed three times using TBS, and the final pellets were resuspended in 40 μL SDS-PAGE sample buffer before being heated to 100°C for 4 min. After centrifugation at 16,100 g for 2 min, the supernatant was subjected to SDS-PAGE followed by Western blotting.
Sample proteins were separated using SDS-PAGE (10%) and transferred to nitrocellulose membranes at 350 mA. The membranes were incubated with 5% non-fat milk in TBS (pH 7.6) for 1 h to prevent non-specific binding and probed with anti-Ca 2 + -ATPase antibody 5f10 (1:500 dilution) overnight at 4°C. The nitrocellulose membranes were washed five times for 3 min using TBS with 0.1% Tween 20, probed using anti-mouse secondary monoclonal antibody (1:2500 dilution) for 1 h and developed using ECL™. The membranes were stripped using 0.2 mol/L glycine (pH 2.2) for 1 h, incubated with polyclonal antirabbit phospho-(Ser/Thr) PKA substrate antibody (1:1000 dilution) and treated as above, with the exception that a secondary anti-rabbit polyclonal antibody was used (1:5000 dilution).
Statistical analysis
The data are presented as mean ± SE. Differences were analyzed using one-way ANOVA, followed by a Newman-Keuls post test. Differences were considered significant at p b 0.05. -ATPase is attained using 10 − 10 mol/L Ang II [8] .
The experiments depicted in Fig. 1 investigated whether a cAMPmediated pathway is involved in maintaining normal Ca -ATPase by Ang II, whereas the toxin alone had no effect. In addition, Fig. 1B demonstrates that addition of db-cAMP abrogated the inhibition of the Ca 2 + pump by Ang II, and had no influence when used in isolation.
G s α protein is associated with AT 2 R in basolateral membranes
G s proteins are linked with stimulation of CTX-stimulated cAMPmediated pathways [19] . Therefore, we investigated a possible structural link between AT 2 R and G s proteins in basolateral membranes (probed against the α subunit). Fig. 2 demonstrates that G s α protein (A) and AT 2 R (C) are present in basolateral membranes, and more importantly, clearly demonstrates that almost all originally membranous G s α are present in immunoprecipitates obtained using the antibody against AT 2 R (B). A negative control of immunoprecipitation using an anti AT 2 R antibody without basolateral membranes, followed by Western blotting for AT 2 R, allowed visualization of the two IgG bands (heavy and light) (D), with molecular masses different from that seen for AT 2 R (compare C and D). 
Specific blockade of PKA impairs Ca
Ang-(3−4) stimulates the membrane-associated PKA in basolateral membranes
The results presented in Fig. 4A demonstrate that Ang-(3−4) stimulated the PKA that is associated to basolateral membranes of proximal tubules [20] even in subfemtomolar concentrations; furthermore, 10 − 14 mol/L Ang-(3−4) stimulated PKA to the same extent as that obtained with db-cAMP (Fig. 4B) . -ATPase via PKA is presented in Fig. 5A . First, the AT 2 R antagonist PD123319 blocked stimulation of membrane-associated PKA activity by Ang- (3−4) ; second, the AT 2 R agonist CGP42112A reproduced the effect of Ang-(3−4). Furthermore, losartan (a selective AT 1 R antagonist) was unable to abolish activation of the kinase by the dipeptide (Fig. 5B ). -ATPase recognized by a specific antibody against small amino acid sequences in proteins phosphorylated by PKA. This hyperphosphorylation obtained with Ang-(3-4) is comparable to that observed in the presence of db-cAMP, and the increase in phosphorylation correlates with the stimulus of PKA activity in vitro (Fig. 4B) . When PKAi is added, the effect of Ang-(3−4) on Ca 2 + -ATPase phosphorylation is almost completely abrogated.
3.7.
Binding of Ang-(3−4) to the AT 2 R generates a probable higher-affinity site for Ang II Despite the aforementioned evidence that Ang-(3−4) exerts its effects via AT 2 R, the peptide could not displace 3 H-Ang II over a wide range of concentrations (Fig. 7A, □) in HEK 293T cells expressing AT 2 R. Unlabeled Ang II exhibited a competition profile where the following equation was adjusted to the experimental points (■): where "bottom" and "top" are the minimum and maximal values of the curve, "X" is the logarithm of the concentration of unlabeled Ang II, and "IC50" is the concentration of unlabeled Ang II that is effective for displacing 50% of the observed the appearance of a probable higher-affinity site for Ang II, with an IC50 approximately four orders of magnitude lower than in the absence of Ang-(3−4) (Fig. 7B) . In this case, the competition profile was obtained using an equation derived for two classes of sites:
where "bottom", "top" and "X" have the definitions outlined above. "Fraction 1" corresponds to parcel of receptors with high affinity for Ang II, and "Fraction 2" corresponds to receptors (sites) with lower affinity for Ang II. The IC50 values for these two classes of sites are represented by Eq. (2). The binding affinity data calculated from these equations are presented in Table 1 .
Discussion
Signaling pathways coupled to AT 1 R receptors are relatively well documented, whereas those linked to AT 2 R remain poorly understood [21, 22] . Herein, we present evidence that Ang-(3−4), in addition to its reported inhibition of the angiotensin converting enzyme (ACE) [5, [23] [24] [25] , can interact with AT 2 R coupled to G s proteins in the basolateral membranes of kidney proximal tubule cells. From a physiological point of view, the concentrations of Ang-(3−4) used during the present study are less than those present in human plasma and renal tissue, where the dipeptide can accumulate [26, 27] . Downstream adenylyl cyclase and PKA activation occurs after interaction of Ang-(3−4) with AT 2 R/G s and culminates in the reactivation of the neighboring plasma membrane Ca 2 + -ATPase inhibited by picomolar Ang II concentrations. Most important in terms of direct evidence concerning the interaction of Ang-(3−4) with the membrane-associated PKA is the stimulation -not previously described -of the kinase by subfemtomolar Ang-(3−4) concentrations (see Fig. 4 ). The results presented in Fig. 6 demonstrating stimulation of the regulatory phosphorylation of Ca -ATPase, which predominates in renal proximal tubule cells and can be phosphorylated by PKA [10] , possesses a specific site for this kinase, localized downstream of the calmodulin binding domain [28, 29] . However, several isoforms of Ca 2 + -ATPase have a threonine residue target for PKC in the pump sequence corresponding to the calmodulin binding domain [29] . It may be speculated that the inhibitory PKC-mediated phosphorylation of the latter in the presence of Ang II [8] is counteracted by the PKA-mediated stimulatory phosphorylation of the former site elicited by Ang-(3−4) (Figs. 4B and 6) . If this were the case, opposite phosphorylations elicited by Ang II and Ang-(3−4) could act by modulating binding of the autoinhibitory domain to the catalytic domain of the pump, a role for phosphorylating processes that was proposed several years ago [30] .
The physiological relevance of the coupled Ang-(3−4)→PKA→ Ca pump [30] [31] [32] [33] , and these oscillations regulate proximal fluid reabsorption [9] . Therefore, the effect of Ang-(3−4) via AT 2 R→G s →adenylyl cyclase→PKA can be considered another pathway in the Ang IImediated Ca 2+ signaling triggered as a result of Ang II binding to AT 1 R
[34], and/or from Ang II direct interaction with ACE [35] . Evidence confirming the relationship between AT 2 R, Ang-(3−4) and the PKA cascade in counteracting the effect of Ang II was obtained from experiments carried out in the presence of PKAi, the specific blocker of the α-catalytic subunit of PKA [10, 18] . The inhibitor impairs reactivation of the Ang II-inhibited Ca 2 + pump by either Ang-(3−4) or the AT 2 R agonist, CGP42112A (Fig. 3) . This was supported by the finding that the AT 2 R agonist stimulates PKA to a comparable extent as cAMP and Ang-(3−4). The close structural relationship of AT 2 R/G s , demonstrated by complete coprecipitation of the G s α protein and the receptor, could be an essential feature guaranteeing their tight functional coupling in proximal tubule cells. AT 2 R and G s participate in downregulation of the ouabain-resistant Na + -ATPase activity by Ang-(1−7) [13] . Therefore, diverse peptides of the RAS family may interact to regulate active ion translocation in proximal tubules via AT 2 R in addition to AT 1 R [9, 20] . The combined targeting of active transporters by locally-formed Ang II-derived peptide may represent a sensitive method of ensuring a perfect paracrine adjustment of ion reabsorption and fluid homeostasis of body fluids by Ang II [36] .
The importance of PKC and PKA-catalyzed phosphorylations in Ang II-mediated regulatory pathways that impact fluid reabsorption across the proximal epithelium has been confirmed recently through phosphoproteomic analysis [37] . Of note, cAMP and Ang-(3−4) reverse the inhibition of Ca (Fig. 6) . Therefore, as aforementioned, it is plausible that Ang II-triggered PKC-mediated inhibitory phosphorylation activates long-range intramolecular communication [38] within the Ca 2 + pump, promoting conformational changes at sites phosphorylated by PKA. As a result, interaction of the autoinhibitory domain and catalytic domain could decrease [30] when reactivation of the pump was physiologically required. Finally, a pivotal question that emerges from such results concerns the type of interaction that Ang-(3−4) plays in the Ang II-AT 2 R axis. In experimental conditions where Ang-(3−4) coexists with Ang II, there is dissociation of AT 1 R/AT 2 R heterodimers [7] , and this seems to be an obligatory requirement to overcome the doubly losartanand PD123329-sensitive inhibition of plasma membrane Ca 2 + -ATPase promoted by 10 − 10 mol/L Ang II [8] . The appearance of a H-Ang II in the presence of increasing concentrations of Ang II (Fig. 7A, ■) , Ang-(3−4) (Fig. 7A, □) or Ang II plus a constant concentration of Ang-(3−4) (Fig. 7B, ■) . Values are mean ± SE of 3 independent experiments performed in duplicate with cells from different cultures. NCP, no competition profile. The binding affinity data were obtained using Eqs. (1) and (2) (see text).
second binding site, with affinity for Ang II in the 10 − 12 mol/L range (IC50 2.9 pmol/L), i.e. four orders of magnitude higher than that observed without Ang-(3-4) (IC50 33.7 nmol/L), is accompanied of a moderate reduction in affinity of the latter site to 114.0 nmol/L (Table 1) . Such alterations in affinity and in the competition profile for Ang II are probably representative of a subpopulation of AT 2 R with altered conformation due to the allosteric interference of Ang-(3−4) binding, consequently responsible for complete reversing of the Ang II-induced inhibition of the Ca 2 + pump [7] . Therefore, Ang-(3−4) would act as an allosteric modulator when bound to the AT 2 R. Therefore, Ang-(3−4) would not directly compete with Ang II, but would be responsible for inducing conformational changes in the receptors, resulting in modification of the Ang II binding profile. Allosteric modulators can modify affinity of the primary agonist for G protein-coupled receptors either when in their monomeric [39] or dimeric states [40] . Therefore, in native proximal tubule membranes, a similar behavior of conformational modification due to the allosteric interference of Ang-(3−4) could occur with AT 2 R/AT 1 R heterodimers [7] . We speculate that this is a key event linked to the counterregulatory action of Ang-(3 − 4). This event would correspond to the structural modifications induced by Ang-(3−4) in receptors that functionally couple a primed, but silent, AT 2 R/G s complex linked to a downstream PKA pathway.
Conclusions
In conclusion, this study has revealed new partners of AT 2 R in renal cells: the components of the cAMP-stimulated kinase pathway resident in basolateral membranes and Ang-(3−4), the latter acting as an allosteric modulator [40] . This expands our understanding concerning AT 2 R functionality and its association with other receptors that participate in renal ion and fluid handling.
